Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat

BioMedical Engineering Online

Volumn 13, Issue 1, 2014, Pages

  Machova Urdzikova, Lucia ^a   Sedlacek, Radek ^c   Suchy, Tomas ^c   Amemori, Takashi ^a   Ruzicka, Jiri ^a   Lesny, Petr ^b   Havlas, Vojtech ^b   Sykova, Eva ^a,b   Jendelova, Pavla ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

Achilles tendon; Mesenchymal stromal cells; Osteogenesis

Indexed keywords

BONE; CELL CULTURE; CELLS; COLLAGEN; DEPOSITS; GLYCOPROTEINS; RATS;

ACHILLES TENDONS; BIOMECHANICAL TESTING; CYTOCHROME C OXIDASE; EXTRACELLULAR MATRICES; GOOD MANUFACTURING PRACTICES; MESENCHYMAL STEM CELL; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

TENDONS;

AGGRECAN; CARPROFEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE; CYCLOSPORIN A; CYTOCHROME C; GENTAMICIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; SODIUM CHLORIDE; VERSICAN;

ACHILLES TENDON; ACHILLES TENDON RUPTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; EXTRACELLULAR MATRIX; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MORPHOMETRICS; MULTIPOTENT STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSSIFICATION; POSTOPERATIVE INFECTION; RAT; SAFETY; STAINING; TENDINITIS; TENDON INJURY; TREATMENT PLANNING; VASCULARIZATION; WOUND HEALING; ANGIOGENESIS; ANIMAL; BIOMECHANICS; CARCINOGENESIS; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; TRANSPLANTATION;

RATTUS;

ACHILLES TENDON; ANIMALS; BIOMECHANICAL PHENOMENA; CARCINOGENESIS; CELL DIFFERENTIATION; COLLAGENASES; EXTRACELLULAR MATRIX; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PLURIPOTENT STEM CELLS; RATS; TENDON INJURIES; WOUND HEALING;

EID: 84899647303     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-13-42     Document Type: Article

References (32)

1. Lovati AB, Corradetti B, Cremonesi F, Bizzaro D, Consiglio AL. Tenogenic differentiation of equine mesenchymal progenitor cells under indirect co-culture. Int J Artif Organs 2012, 35(11):996-1005. 10.5301/ijao.5000129, 23065882.
2. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F, Carlucci F, Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007, 13(12):2949-2955. 10.1089/ten.2007.0108, 17919069.
3. Havlas V, Kotaška J, Lesný P, Sevastyanova O, Trč T. Effect of PRP on healing of arthroscopic rotator cuff repair first experience. Ortopedie 2013, 7:6-9.
4. Ahmad Z, Wardale J, Brooks R, Henson F, Noorani A, Rushton N. Exploring the application of stem cells in tendon repair and regeneration. Arthroscopy 2012, 28(7):1018-1029. 10.1016/j.arthro.2011.12.009, 22381688.
5. Kida Y, Morihara T, Matsuda K, Kajikawa Y, Tachiiri H, Iwata Y, Sawamura K, Yoshida A, Oshima Y, Ikeda T, Fujiwara H, Kawata M, Kubo T. Bone marrow-derived cells from the footprint infiltrate into the repaired rotator cuff. Journal of shoulder and elbow surgery/American Shoulder and Elbow Surgeons 2013, 22(2):197-205.
6. Ruzzini L, Longo UG, Rizzello G, Denaro V. Stem cells and tendinopathy: state of the art from the basic science to clinic application. Muscles Ligaments Tendons J 2012, 2(3):235-238. 3666519, 23738302.
7. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. International Society Cellular Therapy Cytotherapy 2006, 8(4):315-317.
8. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995, 12(1):1-21. 10.1089/neu.1995.12.1, 7783230.
9. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008, 69(7):928-937. 10.2460/ajvr.69.7.928, 18593247.
10. Kuo CK, Tuan RS. Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A 2008, 14(10):1615-1627.
11. Ohnishi S, Sumiyoshi H, Kitamura S, Nagaya N. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 2007, 581(21):3961-3966.
12. Sharma RI, Snedeker JG. Paracrine interactions between mesenchymal stem cells affect substrate driven differentiation toward tendon and bone phenotypes. PLoS One 2012, 7(2):e31504. 3280320, 22355373.
13. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs those from other sources: their biology and role in regenerative medicine. J Dent Res 2009, 88(9):792-806. 2830488,2830488, 19767575.
14. Chowdhury A, Bezuidenhout LW, Mulet-Sierra A, Jomha NM, Adesida AB. Effect of interleukin-1beta treatment on co-cultures of human meniscus cells and bone marrow mesenchymal stromal cells. BMC Musculoskelet Disord 2013, 14:216. 3726416, 23875869.
15. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 2010, 316(20):3417-3424.
16. Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, Wiltfang J, Schallmoser K, Alamein M, Bourke R, Heiner P, Liu Q. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg 2013, 41(2):153-161.
17. Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, Bierling P, Hernigou P, Layrolle P, Rouard H. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010, 31(2):270-278.
18. Parsons P, Butcher A, Hesselden K, Ellis K, Maughan J, Milner R, Scott M, Alley C, Watson JT, Horner A. Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair. J Orthop Trauma 2008, 22(9):595-604.
19. Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, Slaper-Cortenbach IC, Martens AC. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A 2009, 15(12):3741-3751.
20. Lohmann M, Walenda G, Hemeda H, Joussen S, Drescher W, Jockenhoevel S, Hutschenreuter G, Zenke M, Wagner W. Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 2012, 7(5):e37839. 3360602, 22662236.
21. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004, 15(1):29-35.
22. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C, Drescher W, Hutschenreuther G, Zenke M, Ho AD, Wagner W. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 2010, 12(7):888-898.
23. Kumar A, Salimath BP, Stark GB, Finkenzeller G. Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A 2010, 16(3):983-993.
24. Bernstein P, Sticht C, Jacobi A, Liebers C, Manthey S, Stiehler M. Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation. Osteoarthritis Cartilage 2010, 18(12):1596-1607.
25. Corps AN, Robinson AH, Movin T, Costa ML, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006, 45(3):291-294.
26. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 2004, 117(1):3-10.
27. Yamagata M, Shinomura T, Kimata K. Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos. Anat Embryol 1993, 187(5):433-444.
28. Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 2006, 207(2):331-339.
29. Chai W, Ni M, Rui YF, Zhang KY, Zhang Q, Xu LL, Chan KM, Li G, Wang Y. Effect of growth and differentiation factor 6 on the tenogenic differentiation of bone marrow-derived mesenchymal stem cells. Chin Med J (Engl) 2013, 126(8):1509-1516.
30. Tan Q, Lui PP, Rui YF. Effect of in vitro passaging on the stem cell-related properties of tendon-derived stem cells-implications in tissue engineering. Stem Cells Dev 2012, 21(5):790-800. 3295857, 21627568.
31. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P, Huibregtse B, Caplan AI. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999, 5(3):267-277.
32. Gulotta LV, Kovacevic D, Packer JD, Deng XH, Rodeo SA. Bone marrow-derived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model. Am J Sports Med 2011, 39(6):1282-1289.